ImmuneOncia Therapeutics and Lonza have entered into a manufacturing collaboration [...]

Lonza expands its Advanced Synthesis capabilities at Oss, integrating ADC [...]

Synaffix B.V., a Lonza company focused on clinical-stage antibody-drug conjugate [...]

Lonza has signed an agreement to acquire Redberry, a French [...]

Lonza’s Synaffix has signed a licensing agreement with Qurient Therapeutics [...]

RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived [...]

Lonza has appointed Jason Berndt as head of group operations [...]

Lonza has raised its full-year 2025 guidance for its contract [...]

Lonza has unveiled a new model-based development platform, Design2Optimize, which [...]